President & CEO
Sabrina Martucci Johnson is the President and CEO of Daré Bioscience (NASDAQ: DARE), a biopharmaceutical company advancing first-in-category products in women’s health.
She is a recognized innovator at the intersection of science, policy, and capital markets, with a track record of translating breakthrough research into impactful solutions for contraception, menopause, fertility, and sexual health.
Under her leadership, Daré has built a differentiated pipeline and forged creative partnerships with NIH, ARPA-H, and the Gates Foundation, demonstrating how public-private collaboration can accelerate innovation. Named one of Fierce Pharma’s “Most Influential People in Biopharma” in 2023, Ms. Johnson is known for her ability to navigate policy and regulatory landscape while driving shareholder value and advancing health equity.
She brings a mission-driven, pragmatic perspective on how biotech leaders can work with policymakers and investors to shape the future of healthcare innovation.